Breast Neoplasms
Showing 9976 - 10000 of >10,000
Cholangiocarcinoma, Biliary Tract Cancer, HER-2 Protein Overexpression Trial in Seoul (Trastuzumab)
Completed
- Cholangiocarcinoma
- +3 more
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2021
Chemotherapy on Brain in Newly Diagnosed Early-Stage Breast
Completed
- Breast Cancer
- +6 more
- trastuzumab
- +11 more
-
San Francisco, CaliforniaUCSF Helen Diller Family Comprehensive Cancer Center
Nov 21, 2017
Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Chapel Hill (BRAF inhibitor dabrafenib and MEK inhibitor
Completed
- Stage III Melanoma
- +3 more
- BRAF inhibitor dabrafenib and MEK inhibitor trametinib
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center, University of North Caro
Nov 3, 2020
Surgical Resection, Stereotactic Body Radiotherapy, Lung Cancer Trial in Hamilton (Surgical resection and stereotactic body
Recruiting
- Surgical Resection
- +3 more
- Surgical resection and stereotactic body radiation therapy (SBRT)
-
Hamilton, Ontario, CanadaMcMaster University/St. Joseph's Hospital Healthcare
Feb 23, 2021
Breastfeeding, Breast Milk Expression, Pregnancy Related Trial (Education)
Not yet recruiting
- Breastfeeding
- +2 more
- Education
- (no location specified)
Jun 5, 2023
Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)
Active, not recruiting
- Polycythemia Vera (PV)
- Essential Thrombocythemia (ET)
-
Mannheim, Baden-Württemberg, Germany
- +23 more
Oct 6, 2020
Metastatic Colorectal Cancer Trial in Worldwide (Trifluridine/tipiracil + bevacizumab, Capecitabine + bevacizumab)
Completed
- Metastatic Colorectal Cancer
- Trifluridine/tipiracil + bevacizumab
- Capecitabine + bevacizumab
-
Camperdown, Australia
- +56 more
Oct 3, 2021
Progression-Free-Survival, Recurrence, Overall Survival Trial in Shanghai, Zhejiang (Traditional Chinese medicine)
Unknown status
- Progression-Free-Survival
- +2 more
- Traditional Chinese medicine
-
Shanghai, Shanghai, China
- +4 more
Nov 4, 2017
Small Cell Lung Cancer and Other Solid Tumors Trial in Guangzhou (APG-1252)
Terminated
- Small Cell Lung Cancer and Other Solid Tumors
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 24, 2021
Exclusive Breastfeeding, Breastfeeding Support Trial in Istanbul (Breastfeeding Support Provided to Mothers Through WhatsApp
Completed
- Exclusive Breastfeeding
- Breastfeeding Support
- Breastfeeding Support Provided to Mothers Through WhatsApp Messaging Application
-
İstanbul, Üsküdar, TurkeyZeynep Kamil Women And Chıldren Dıseases Tranıng And Research Ho
Nov 26, 2021
Breast Cancer Trial in Durham (Mobile Health Pain Coping Skills Training (mPCST))
Recruiting
- Breast Cancer
- Mobile Health Pain Coping Skills Training (mPCST)
-
Durham, North CarolinaDuke University Medical Center
Oct 25, 2021
Multiple Myeloma Trial in Odense (Exercise)
Completed
- Multiple Myeloma
- Exercise
-
Odense, DenmarkOdense University Hospital
Dec 15, 2020
Cardiovascular Diseases Trial (Melatonin)
Not yet recruiting
- Cardiovascular Diseases
- Melatonin
- (no location specified)
Nov 10, 2020
Kidney Tumors Trial in Worldwide (Axitinib (AG-013736), Sorafenib)
Sarcoma,Soft Tissue Trial in Seoul (pemetrexed+cisplatin)
Recruiting
- Sarcoma,Soft Tissue
-
Seoul, Korea, Republic ofSeverance Hospital
Apr 20, 2021
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Worldwide (Fasinumab, Naproxen, Fasinumab-matching )
Completed
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Fasinumab
- +3 more
-
Mesa, Arizona
- +138 more
Oct 18, 2022
Peripheral Arterial Disease, Claudication Trial in Berlin (CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon
Completed
- Peripheral Arterial Disease
- Claudication
- CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
- Bare Percutaneous Transluminal Angioplasty Balloon Catheter
-
Berlin, GermanyCenter for Diagnostic Radiology and Minimally Invasive Therapy
Oct 11, 2021
And Safety Of Sertraline In Posttraumatic Stress Disorder
Completed
- Posttraumatic Stress Disorder
- sertraline (Zoloft)
-
Kurume-city, Fukuoka, Japan
- +3 more
Jan 25, 2021
Diabetes, Type 2 Trial in United States (Semaglutide 2.4 mg, Cagrilintide 2.4 mg, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide 2.4 mg
- +3 more
-
Birmingham, Alabama
- +17 more
Mar 14, 2022
Family History in a Singapore Oncology Population
Completed
- Breast Cancer
- MeTree
-
Singapore, SingaporeNCCS Cancer Genetics Clinic
Nov 24, 2020
Breast Cancer Trial in Marseille, Toulon (molecular alteration)
Recruiting
- Breast Cancer
- molecular alteration
-
Marseille, France
- +1 more
Sep 1, 2017
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Insulin Glargine
-
Anaheim, California
- +215 more
Jan 21, 2022
NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- Capmatinib
- +2 more
-
Fayetteville, Arkansas
- +7 more
Jan 21, 2022
COPD Trial in China, Japan, Korea, Republic of (tetomilast (OPC-6535), )
Completed
- Chronic Obstructive Pulmonary Disease
- tetomilast (OPC-6535)
- placebo
-
Central China Area, China
- +8 more
Apr 5, 2021
Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)
Completed
- Metastatic Colorectal Cancer
-
Stockton, California
- +151 more
Sep 8, 2022